These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28113030)

  • 1. Modification of Authorship Restrictions for Research Studies in the American Society of Clinical Oncology Conflict of Interest Policy.
    American Society of Clinical Oncology
    J Clin Oncol; 2017 Mar; 35(7):799-800. PubMed ID: 28113030
    [No Abstract]   [Full Text] [Related]  

  • 2. American Society of Clinical Oncology: Policy for Relationships With Companies.
    American Society of Clinical Oncology
    J Clin Oncol; 2017 Mar; 35(7):796-798. PubMed ID: 28113027
    [No Abstract]   [Full Text] [Related]  

  • 3. The changing landscape of conflict of interest supports further study of American Society of Clinical Oncology authorship restrictions for research studies.
    American Society of Clinical Oncology, Alexandria, VA
    J Clin Oncol; 2014 Mar; 32(9):867-8. PubMed ID: 24516029
    [No Abstract]   [Full Text] [Related]  

  • 4. I'm Conflicted. Are You?
    Tempero M
    J Natl Compr Canc Netw; 2018 Nov; 16(11):1273. PubMed ID: 30442729
    [No Abstract]   [Full Text] [Related]  

  • 5. American Society of Clinical Oncology: Policy for relationships with companies.
    American Society of Clinical Oncology
    J Clin Oncol; 2013 Jun; 31(16):2043-6. PubMed ID: 23610118
    [No Abstract]   [Full Text] [Related]  

  • 6. American Society of Clinical Oncology policy for relationships with companies: background and rationale.
    American Society of Clinical Oncology
    J Clin Oncol; 2013 Jun; 31(16):2037-42. PubMed ID: 23610121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ghostwriting at elite academic medical centers in the United States.
    Lacasse JR; Leo J
    PLoS Med; 2010 Feb; 7(2):e1000230. PubMed ID: 20126384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Society of Clinical Oncology: background for update of conflict of interest policy.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2387-93. PubMed ID: 12721280
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of the American Society of Clinical Oncology's Conflict of Interest Policy on Information Overload.
    Boothby A; Wang R; Cetnar J; Prasad V
    JAMA Oncol; 2016 Dec; 2(12):1653-1654. PubMed ID: 27560393
    [No Abstract]   [Full Text] [Related]  

  • 10. Raising concern about the American Society of Clinical Oncology conflict of interest policy amendment.
    Vera-Badillo FE; Ocana A; Templeton AJ; Tibau A; Amir E; Tannock IF
    J Clin Oncol; 2014 Oct; 32(28):3197. PubMed ID: 25092777
    [No Abstract]   [Full Text] [Related]  

  • 11. Should Failure to Disclose Significant Financial Conflicts of Interest Be Considered Research Misconduct?
    Botkin JR
    JAMA; 2018 Dec; 320(22):2307-2308. PubMed ID: 30422234
    [No Abstract]   [Full Text] [Related]  

  • 12. American Society Of Clinical Oncology: revised conflict of interest policy.
    American Society of Clinical Oncology
    J Clin Oncol; 2006 Jan; 24(3):519-21. PubMed ID: 16365173
    [No Abstract]   [Full Text] [Related]  

  • 13. New copyright transfer and conflict-of-interest process for all authors.
    Pediatr Emerg Care; 2012 Apr; 28(4):404. PubMed ID: 22472664
    [No Abstract]   [Full Text] [Related]  

  • 14. Improving the disclosure of conflicts of interest in medicine.
    Arnold D
    Clin Adv Hematol Oncol; 2019 Jul; 17(7):393-394. PubMed ID: 31449505
    [No Abstract]   [Full Text] [Related]  

  • 15. Cure unwanted? Exploring the chronic Lyme disease controversy and why conflicts of interest in practice guidelines may be guiding us down the wrong path.
    Ferguson J
    Am J Law Med; 2012; 38(1):196-224. PubMed ID: 22497097
    [No Abstract]   [Full Text] [Related]  

  • 16. Disclosure of financial conflicts of interest by authors publishing in the Journal of Clinical Oncology.
    Go RS; Mathiason MA; Lee JA
    J Clin Oncol; 2008 Jan; 26(3):509-10; author reply 510-1. PubMed ID: 18202429
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management policy for links of interest: 30 years after].
    Chabot JM
    Rev Prat; 2014 Jan; 64(1):109-10. PubMed ID: 24649562
    [No Abstract]   [Full Text] [Related]  

  • 18. Financial conflicts of interest in economic analyses in oncology.
    Jang S; Chae YK; Majhail NS
    Am J Clin Oncol; 2011 Oct; 34(5):524-8. PubMed ID: 21441858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing conflicts of interest: who is responsible?
    Nahai F
    Aesthet Surg J; 2009; 29(4):330-2. PubMed ID: 19717068
    [No Abstract]   [Full Text] [Related]  

  • 20. Conflict of interest in industry-sponsored drug development.
    Emanuel EJ
    Clin Adv Hematol Oncol; 2007 Apr; 5(4):265-7. PubMed ID: 17607285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.